SouthSouth

Market Entry & Growth in South

South Korea is one of Asia's most advanced healthcare markets, with rapid MFDS approval pathways and high adoption of premium medical technology. Taevas bridges global manufacturers into this high-value ecosystem.

MFDS
KGMP
ISO 13485
Get South Assessment
$180B+
Healthcare Market
#7
Global Pharma Market Rank
51.7M
Population
17
Provinces & Cities Covered
Industries We Support

Four Industries. One South Team.

Select an industry to see regulatory pathways, services, and how Taevas supports your South market entry.

Medical Devices & Equipment

Ministry of Food and Drug Safety (MFDS)

South Korea is a top-tier Asian medical device market driven by advanced hospitals and strong domestic demand for imaging, IVD, and surgical technology. Devices are classified into four risk classes under MFDS oversight. Taevas manages classification, technical documentation, and KGMP alignment for smooth market entry.

Regulatory Pathways

Low Risk
Class I Notification

Low-risk devices require simple pre-market notification to MFDS before importation and sale.

High Risk
Class II-IV Approval

Higher-risk devices undergo MFDS technical review and clinical data assessment prior to licensing.

Mandatory
Import Business Licence

An importer licence and Korea-based license holder are mandatory to bring devices into the country.

Ongoing
Post-Market Surveillance

Ongoing adverse event reporting and re-evaluation obligations apply throughout the product lifecycle.

Our Services for Medical Devices in South Korea

02
Product Registration

End-to-end MFDS classification, technical file compilation, and device licensing submissions.

03
Legal Representation

Acting as your Korea license holder and regulatory point of contact with MFDS.

04
Imports & Shipments

Customs clearance, import declaration, and cold-chain logistics into Korean ports.

05
Warehousing & Inventory

KGMP-compliant storage and inventory management across Seoul and Busan hubs.

06
Distributor Support

Vetting and managing Korean distributors and hospital supply networks.

07
KOL Management

Engaging Korean key opinion leaders and academic hospitals for clinical adoption.

08
End-to-End Marketing

Localised marketing, conference presence, and digital campaigns for the Korean market.

09
Sales Support

Tender participation, HIRA reimbursement listing, and hospital sales enablement.

Why Taevas South

Why Global Brands Choose Taevas for South

Taevas combines deep MFDS regulatory expertise with on-the-ground commercial networks to accelerate your entry into South Korea's premium life-sciences market.

Compliance

MFDS Regulatory Mastery

Our specialists navigate MFDS classification, CTD dossiers, and KGMP requirements with precision.

Global Reach

Single Global Partner

One accountable team manages South Korea alongside 24 other Taevas markets worldwide.

Speed

Faster Time to Market

Pre-validated pathways and local expertise compress registration timelines significantly.

Partnerships

Trusted Local Networks

Established relationships with Korean distributors, hospitals, and retail channels.

Influence

KOL & Academic Access

Direct engagement with Korean key opinion leaders and top-tier academic hospitals.

Experience

Proven Track Record

A dedicated Korea team delivering end-to-end market entry across four industries.

South Korea | Taevas Global